McKesson Co. (MCK) Shares Sold by Eaton Vance Management
Eaton Vance Management reduced its position in McKesson Co. (NYSE:MCK) by 1.3% in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,776 shares of the company’s stock after selling 489 shares during the quarter. Eaton Vance Management’s holdings in McKesson were worth $4,878,000 at the end of the most recent reporting period.
Other hedge funds have also recently bought and sold shares of the company. Fort L.P. acquired a new stake in shares of McKesson in the second quarter valued at approximately $110,000. Flagship Harbor Advisors LLC acquired a new stake in shares of McKesson in the second quarter valued at approximately $118,000. Reilly Financial Advisors LLC boosted its holdings in shares of McKesson by 506.8% in the third quarter. Reilly Financial Advisors LLC now owns 898 shares of the company’s stock valued at $119,000 after acquiring an additional 750 shares during the period. Bray Capital Advisors acquired a new stake in shares of McKesson in the third quarter valued at approximately $123,000. Finally, FNY Investment Advisers LLC boosted its holdings in shares of McKesson by 88.6% in the third quarter. FNY Investment Advisers LLC now owns 1,120 shares of the company’s stock valued at $148,000 after acquiring an additional 526 shares during the period. 85.46% of the stock is owned by institutional investors and hedge funds.
Shares of NYSE MCK opened at $124.94 on Friday. The company has a debt-to-equity ratio of 0.69, a current ratio of 0.99 and a quick ratio of 0.56. McKesson Co. has a 1-year low of $117.19 and a 1-year high of $178.86. The firm has a market cap of $24.43 billion, a P/E ratio of 9.90, a P/E/G ratio of 1.42 and a beta of 1.03.
The business also recently declared a quarterly dividend, which will be paid on Wednesday, January 2nd. Investors of record on Monday, December 3rd will be issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 1.25%. The ex-dividend date is Friday, November 30th. McKesson’s dividend payout ratio is presently 12.36%.
MCK has been the subject of several research analyst reports. ValuEngine raised McKesson from a “strong sell” rating to a “sell” rating in a report on Monday, October 29th. Mizuho reissued a “hold” rating and issued a $133.00 price objective on shares of McKesson in a report on Sunday, August 12th. Royal Bank of Canada set a $155.00 price objective on McKesson and gave the company a “hold” rating in a report on Friday, October 26th. Barclays decreased their price target on McKesson from $150.00 to $136.00 and set an “equal weight” rating for the company in a report on Friday, October 26th. Finally, Morgan Stanley decreased their price target on McKesson from $142.00 to $130.00 and set an “equal weight” rating for the company in a report on Monday, December 3rd. Two equities research analysts have rated the stock with a sell rating, seven have given a hold rating and seven have given a buy rating to the company. McKesson presently has a consensus rating of “Hold” and a consensus target price of $147.63.
ILLEGAL ACTIVITY WARNING: “McKesson Co. (MCK) Shares Sold by Eaton Vance Management” was first published by Watch List News and is the property of of Watch List News. If you are accessing this story on another site, it was copied illegally and republished in violation of US & international trademark & copyright law. The correct version of this story can be read at https://www.watchlistnews.com/mckesson-co-mck-shares-sold-by-eaton-vance-management/2669588.html.
McKesson Company Profile
McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.
Featured Story: Stock Selection – What is cash flow?
Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).
Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.